share_log

CVS Health | SC 13G: Statement of acquisition of beneficial ownership by individuals-Dodge & Cox(5.0%)

CVS Health | SC 13G: Statement of acquisition of beneficial ownership by individuals-Dodge & Cox(5.0%)

西維斯健康 | SC 13G:超過5%持股股東披露文件-Dodge & Cox(5.0%)
美股SEC公告 ·  2024/11/14 02:03

Moomoo AI 已提取核心訊息

On September 30, 2024, investment firm Dodge & Cox filed a Schedule 13G with the United States Securities and Exchange Commission, disclosing a 5.0% ownership stake in CVS Health Corporation, amounting to 63,030,690 shares. The filing indicates that Dodge & Cox has sole voting power over 59,793,915 shares and sole dispositive power over all 63,030,690 shares. The investment advisor, registered under section 203 of the Investment Advisors Act of 1940, asserts that the acquisition of these shares is part of its ordinary course of business and not intended to change or influence control of CVS Health. The filing was certified as true and correct by Katherine M. Primas on behalf of Dodge & Cox on November 13, 2024.
On September 30, 2024, investment firm Dodge & Cox filed a Schedule 13G with the United States Securities and Exchange Commission, disclosing a 5.0% ownership stake in CVS Health Corporation, amounting to 63,030,690 shares. The filing indicates that Dodge & Cox has sole voting power over 59,793,915 shares and sole dispositive power over all 63,030,690 shares. The investment advisor, registered under section 203 of the Investment Advisors Act of 1940, asserts that the acquisition of these shares is part of its ordinary course of business and not intended to change or influence control of CVS Health. The filing was certified as true and correct by Katherine M. Primas on behalf of Dodge & Cox on November 13, 2024.
2024年9月30日,投資公司道富公司向美國證券交易委員會提交了13G表格,披露在西維斯健康公司的所有板塊中擁有5.0%的持股比例,共計63,030,690股。該申報顯示,道富公司對59,793,915股擁有唯一的表決權,對所有63,030,690股擁有唯一的處分權。作爲投資顧問,根據1940年投資顧問法第203條註冊的道富公司聲稱,收購這些股份是其正常業務的一部分,並非旨在改變或影響對西維斯健康公司的控制。申報在2024年11月13日由道富公司代表Katherine m. Primas簽署確認屬實和正確。
2024年9月30日,投資公司道富公司向美國證券交易委員會提交了13G表格,披露在西維斯健康公司的所有板塊中擁有5.0%的持股比例,共計63,030,690股。該申報顯示,道富公司對59,793,915股擁有唯一的表決權,對所有63,030,690股擁有唯一的處分權。作爲投資顧問,根據1940年投資顧問法第203條註冊的道富公司聲稱,收購這些股份是其正常業務的一部分,並非旨在改變或影響對西維斯健康公司的控制。申報在2024年11月13日由道富公司代表Katherine m. Primas簽署確認屬實和正確。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息